<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
                                                            January 10, 2025

Jerome Silvey
Chief Executive Officer
EQV Ventures Acquisition Corp. II
1090 Center Drive
Park City, UT 84098

       Re: EQV Ventures Acquisition Corp. II
           Draft Registration Statement on Form S-1
           Submitted December 9, 2024
           CIK No. 0002042902
Dear Jerome Silvey:

       We have reviewed your draft registration statement and have the
following comments.

       Please respond to this letter by providing the requested information and
either
submitting an amended draft registration statement or publicly filing your
registration
statement on EDGAR. If you do not believe a comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

      After reviewing the information you provide in response to this letter
and your
amended draft registration statement or filed registration statement, we may
have additional
comments.

Draft Registration Statement on Form S-1 submitted December 9, 2024
Cover Page

1.     Please revise the cover page to state whether the exercise of the
private warrants on a
       cashless basis and the conversion of the working capital loans into
units may result in
       a material dilution of the purchasers' equity interests. See Item
1602(a)(3) of
       Regulation S-K.
2.     We note disclosure on page 20 that if you increase or decrease the size
of the offering,
       you will take steps to maintain the ownership of your sponsor (and its
permitted
       transferees) at 20% of issued and outstanding ordinary shares upon
consummation of
       this offering. Please revise disclosure on your cover page to address
this potential
       adjustment to the number of Class B shares held by the sponsor and its
affiliates
       pursuant to Item 1602(a)(3) of Regulation S-K.
 January 10, 2025
Page 2

Summary
Conflicts of Interest, page 35

3.     Please expand this section of your Summary to refer to your sponsor and
its affiliates
       and promoters and their conflicts of interest in this discussion, as
required by Item
       1602(b)(7) of Regulation SK. For instance, include disclosure of
conflicts resulting
       from the repayment of sponsor loans and describe the financial interests
of the
       sponsor, officers and directors to provide more quantitative information
about the
       value of their investments in founder shares and private warrants that
may be lost if a
       business combination does not occur. Please also disclose that you are
not prohibited
       from engaging in a business combination with a target that has a
relationship with
       entities that may be affiliated with your sponsor, affiliates,
promoters, officers,
       directors or existing holders as noted on page 57.
Risk Factors
If we seek shareholder approval of our initial business combination...., page
42

4.     We note disclosure here that your sponsor and directors and executive
officers have
       agreed to vote their founder shares, private placement shares and any
public shares
       purchased during or after this offering or in the private placement in
favor of your
       initial business combination We also note disclosure on page 124 that
your sponsor,
       directors, officers, advisors or their affiliates may purchase shares in
privately
       negotiated transactions or in the open market prior to completion of
your initial
       business combination. Please revise to explain how such purchases would
comply
       with the requirements of Rule 14e-5 under the Exchange Act. Refer to
Tender Offer
       Rules and Schedules Compliance and Disclosure Interpretation 166.01 for
guidance.
If we are deemed to be an investment company under the Investment Company
Act...., page
50

5.     We note your risk factor disclosure on pages 50 through 52 addressing
the extent to
       which you could be deemed to be an investment company and the mitigation
       measures you may implement. We also note your statement that by
restricting the
       investment of the proceeds to government securities you intend to avoid
being deemed
       an "investment company." Please revise to include disclosure that
notwithstanding
       your investment activities or these mitigation measures you could still
be deemed to
       be or have been an investment company at any time since your inception.
In addition,
       please confirm that if your facts and circumstances change over time,
you will update
       your disclosure to reflect how those changes impact the risk that you
may be
       considered to be operating as an unregistered investment company.
Use of Proceeds, page 87

6.     We note that you have included the cost for the office space,
administrative and
       support services for only 12 months, although you have up to 24 months
to complete
       an initial business combination. With a view toward revised disclosure
in the table,
       please tell us why you have not included costs assuming you continue for
a 24-month
       period and how you expect to cover those costs if not from proceeds held
outside the
       trust.
 January 10, 2025
Page 3

Dilution, page 91

7.     We note the tabular presentation of dilution at quartile intervals.
Please expand your
       disclosure, outside the table, to describe each material potential
source of future
       dilution following your registered offering, including sources not
included in the table
       with respect to the determination of net tangible book value per share,
as adjusted.
       Your revisions should address, but not be limited to, founder shares'
anti-dilution
       rights, shares that may be issued in connection with the closing of your
initial business
       combination, additional financing(s) in connection with the closing of
your initial
       business combination, and up to $1,500,000 of working capital loans that
may be
       convertible into private placement warrants. Refer to Item 1602(c) of
Regulation S-K.
Principal Shareholders
Restrictions on Transfers of Founder Shares and Private Placement Units, page
143

8.     Please disclose in tabular format the material terms of any agreement,
arrangement, or
       understanding regarding restrictions on whether and when the SPAC
sponsor and its
       affiliates may sell securities of the company as required by Item
1603(a)(9).
9.     Please revise the disclosure on page 143 and similar disclosure
elsewhere in the
       prospectus to address whether there are any circumstances or
arrangements under
       which your sponsor or affiliates have or could indirectly transfer
ownership of
       your securities, such as through the transfer of sponsor membership
interests. See
       Item 1603(a)(6) of Regulation S-K. If such circumstances or arrangements
exist, or if
       there are no limitations on the possible transfer of sponsor membership
interests,
       please disclose this and include risk factor disclosure about the
possibility that
       ownership and control of the sponsor may be transferred to another party
or that
       EQV Ventures Sponsor II LLC may be removed as sponsor before identifying
       and completing a business combination.
Exhibits

10.    We note the form of legal opinion submitted as Exhibit 5.2. Please
ensure the
       executed and filed legal opinion is not limited to whether holders of
ordinary shares
       are liable, solely because of security holder status, for additional
assessments or calls
       on the security by the registrant; the opinion as to whether the shares
are non-
       assessable should also address whether shareholders are liable to the
registrant's
       creditors. Please refer to Section II.B.1.a of Staff Legal Bulletin No.
19, Legality and
       Tax Opinions in Registered Offerings (October 14, 2011).
       Please contact Peter McPhun at 202-551-3581 or Mark Rakip at
202-551-3573 if you
have questions regarding comments on the financial statements and related
matters. Please
contact Ronald (Ron) E. Alper at 202-551-3329 or Mary Beth Breslin at
202-551-3625 with
any other questions.



                                                              Sincerely,

                                                              Division of
Corporation Finance
 January 10, 2025
Page 4

                          Office of Real Estate & Construction
cc:   Julian J. Seiguer
</TEXT>
</DOCUMENT>
